Evidence mapPaperPMID 41753645Full record

ArticleMicroorganisms2026

Deciphering the Arterial and Venous Blood Bacterial DNA Profile: Pioneering Insights into Coronary Heart Disease Etiology and Progression.

Mengru Liu, Lin Zhao, Tianli Li, Xuelin Li, Hong Jiang, Peng Yang

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mengru LiuDepartment of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.ORCID 0000-0003-0856-7223
Lin ZhaoDepartment of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.ORCID 0000-0003-4082-5931
Tianli LiDepartment of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.
Xuelin LiDepartment of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.
Hong JiangDepartment of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.
Peng YangDepartment of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.

Funding

Elite Medical Professionals Project of China-Japan Friendship Hospital No. ZRJY2023-QM11National Key Research and Development Program of China 2023YFC3503702
6 · The paper itself

Abstract

backgroundCoronary heart disease (CHD) is the leading cause of death and disability worldwide. The human microbiota, particularly gut bacteria, plays a role in the development of CHD. However, determining the contribution of gut bacteria translocation to systemic circulation in the progression of atherosclerosis remains challenging. METHODS AND

resultsIn this exploratory study, we conducted 16S rRNA-based metagenomic analysis to characterize systemic bacterial profiles in a cohort of 27 patients with CHD (9 with severe coronary artery stenosis and 18 with mild to moderate stenosis). We compared microbial diversity between arterial and venous blood and across different blood fractions. For the first time, we observed higher microbial diversity in plasma than in serum. We also identified differences in microbial richness among arterial whole blood, venous whole blood, arterial plasma, venous plasma, arterial serum, and venous serum, with 15, 22, 43, 10, 4, and 3 genera showing significant differences, respectively. Many of the detected blood taxa belonged to genera typically found in intestinal, oral, or skin microbiota, although their precise source cannot be determined from this study.

conclusionsOur study provides preliminary evidence of distinct bacterial profiles between arterial and venous blood fractions in patients with CHD, as determined by 16S rRNA sequencing. These findings should be interpreted with caution given the small sample size and the absence of a healthy control group, and they warrant confirmation in larger, controlled studies.

Indexed as

16S rRNA sequencingcoronary heart diseasemetagenomicsmicrobial diversitymicrobiota

Identifiers

PMID41753645
PMCPMC12943319

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.